The U.S. Department of Health and Human Services (HHS) has launched a public-private partnership to create a U.S.-based, high-speed, high-volume emergency drug packaging solution using low-cost prefilled syringes. Working with HHS’ Office of the Assistant Secretary for Preparedness and Response (ASPR), the new consortium for Rapid Aseptic Packaging of Injectable Drugs, or RAPID, will enable ...
On Wednesday, the Health Resources and Services Administration (HRSA) launched an information collection effort to support the Trump Administration’s response to the COVID-19 pandemic, surveying HRSA-funded health centers on their involvement in the COVID-19 response, including whether they are offering diagnostic tests. This effort was made possible by a Paperwork Reduction Act waiver issued pursuant ...
In response to the now global pandemic, the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR), continues to work with its public-private partners to find solutions to mitigate the public health impact of the coronavirus disease 2019 (COVID-19). Part of this landscape ...
Today, the Office for Civil Rights (OCR) at the U.S Department of Health and Human Services (HHS) announced, effective immediately, that it will exercise its enforcement discretion and will waive potential penalties for HIPAA violations against health care providers that serve patients through everyday communications technologies during the COVID-19 nationwide public health emergency. This exercise ...
On Tuesday, the Trump Administration and the Department of Health and Human Services (HHS) announced unprecedented steps to expand Americans’ access to telehealth services during the COVID-19 outbreak. The Centers for Medicare & and Medicaid Services (CMS) expanded Medicare coverage for telehealth visits, the HHS Office for Civil Rights (OCR) announced it will waive potential ...
On Monday, the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health announced that a Phase 1 clinical trial evaluating an investigational vaccine designed to protect against COVID-19 has begun at Kaiser Permanente Washington Health Research Institute in Seattle, funded by NIH. HHS Secretary Alex Azar issued the following statement: ...
On Friday, HHS Secretary Alex Azar issued the following statement regarding President Trump’s declaration that the COVID-19 outbreak in the United States represents a national emergency: “President Trump continues to take smart, aggressive, and comprehensive steps to protect the American people from the threat of COVID-19. His travel restrictions worked at slowing the spread of ...
On Thursday, March 12, Health and Human Services Secretary Alex Azar designated Admiral Brett Giroir, M.D., Assistant Secretary for Health and head of the Public Health Service, to coordinate COVID-19 diagnostic testing efforts among Public Health Service agencies, including the Centers for Disease Control and Prevention and the Food and Drug Administration, as well as ...
Two diagnostic tests that may detect severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) in approximately one hour will receive advanced development support from the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR). The Biomedical Advanced Research and Development Authority (BARDA) within ASPR will provide approximately $679,000 ...
HHS Secretary Alex Azar issued the following statement on President Trump’s Oval Office address regarding the COVID-19 outbreak: “President Trump’s address to the American people laid out bold new steps he is taking to protect our country from COVID-19 and alleviate the economic impacts of the pandemic. Some criticized the President’s decisive steps early on ...